Spinraza Injection, Solution
Product Images NDC 64406-036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spinraza (NDC 64406-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Spi02 0014 01)

FDA Label Image

Figure 1 (Spi02 0014 02)

FDA Label Image

Figure 2 (Spi02 0014 03)

Figure 2 (Spi02 0014 03)
This appears to be a graph showing the hazard ratio of SPINRAZA to a sham treatment over time (in weeks). The text includes some numbers and a few other words, but it is not possible to generate a useful description.*
FDA Label Image

Figure 3 (Spi02 0014 04)

FDA Label Image

Principal Display Panel (Spinraza 12mg/5ml Carton Label)

Principal Display Panel (Spinraza 12mg/5ml Carton Label)
Spinraza is a medication that is available in a single-use vial for intrathecal injection only. Each vial contains a sterile solution of 12mg/5mL or 2.4mg/mL of nusinersen. It is a prescription-only medication and any unused portion of the vial should be discarded after use. The National Drug Code (NDC) for Spinraza is 64406-058-01.*
FDA Label Image

Principal Display Panel (Spinraza 12mg/5ml Vial Label)

Principal Display Panel (Spinraza 12mg/5ml Vial Label)
This is a medication called Spinraza (nusinersen) used for intrathecal use only. It comes in an injection form and the concentration is 2.4mg/mL. The National Drug Code (NDC) for this medication is 64406-058-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.